Abilify and Valcyte drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Abilify (aripiprazole) and Valcyte (valganciclovir hydrochloride). Common drug interactions include vomiting among females and completed suicide among males.

The phase IV clinical study analyzes what interactions people have when they take Abilify and Valcyte. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.

What is Valcyte?

Valcyte has active ingredients of valganciclovir hydrochloride. It is often used in cmv - immunocompromised host. eHealthMe is studying from 6,409 Valcyte users. Check the latest studies of Valcyte.

On Jul, 05, 2026

13 people who take Abilify and Valcyte together, and have interactions are studied.

What are the common drug interactions of Abilify and Valcyte, by gender? *:

female:

Vomiting
Chest discomfort
Chronic kidney disease
Clostridium colitis (inflammation of colon by clostridium difficile bacteria infection)
Cough
Lung transplant
Lung transplant rejection (failure of lung transplant)
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Nephropathy (damage to or disease of a kidney)
Renal failure (kidney dysfunction)

male:

Completed suicide (act of taking one's own life)
Death

What are the common drug interactions of Abilify and Valcyte, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Chest discomfort
Cough
Lung transplant
Lung transplant rejection (failure of lung transplant)
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
Rhinovirus infection
Transplant rejection (a transplant material is not worked)

30-39:

n/a

40-49:

Completed suicide (act of taking one's own life)

50-59:

Chronic kidney disease
Clostridium colitis (inflammation of colon by clostridium difficile bacteria infection)
Nephropathy (damage to or disease of a kidney)
Renal failure (kidney dysfunction)

60+:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)
Enterococcal infection
Graft loss (graft failure)
Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
Serratia bacteraemia (bacterial blood infection)
Staphylococcal bacteraemia (a bacterial infection of blood)
Transplant rejection (a transplant material is not worked)
Vomiting
Death

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 23.08%
Stress And Anxiety: 2 people, 15.38%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 15.38%
Pain: 2 people, 15.38%
Cystic Fibrosis (disease of the secretary glands): 2 people, 15.38%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 15.38%
Bipolar Disorder (mood disorder): 2 people, 15.38%
Progressive Multifocal Leukoencephalopathy (rapidly progressive neuromuscular disease caused by opportunistic infection of brain cells): 1 person, 7.69%
Hiv Infection: 1 person, 7.69%
Hairy Cell Leukaemia (a type of blood cancer): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and Valcyte?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously